
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancer.
Journal: Journal of the National Cancer Institute
Published: February 05, 2026
Outcomes and treatment patterns in germline BRCA1/2 carriers from two matched cohort studies.
Journal: JNCI cancer spectrum
Published: January 29, 2026
Health Care Utilization and Follow-Up Care in Young Adult Breast Cancer Survivors.
Journal: JCO oncology practice
Published: September 24, 2025
Long-Term Locoregional Outcomes in a Contemporary Cohort of Young Women With Breast Cancer.
Journal: JAMA surgery
Published: July 23, 2025
Postpartum breast cancer: evidence for a distinct phenotype.
Journal: Journal of the National Cancer Institute
Published: May 23, 2025
Fertility preservation and fertility treatment use in young breast cancer survivors reporting a live birth.
Journal: Fertility and sterility
Published: May 13, 2025
Association of Tumor-Infiltrating Lymphocyte Subtypes with Clinical Characteristics and Prognosis in Young Women with Hormone Receptor-Positive Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 14, 2025
Association of tumor-infiltrating lymphocyte subtypes with clinical characteristics and prognosis in young women with hormone receptor-positive breast cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 14, 2025
Association of tumor-infiltrating lymphocyte subtypes with clinical characteristics and prognosis in young women with hormone receptor-positive breast cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 14, 2025
Financial Difficulty Over Time in Young Adults With Breast Cancer.
Journal: JAMA network open
Published: November 13, 2024
Optimizing Postneoadjuvant Treatment of Residual Breast Cancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy: A Combined Analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE Clinical Trials.
Journal: Clinical breast cancer
Published: October 31, 2024
Last Updated: 09/26/2026